Monique G. de Sain-van der Velden

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project

David McHugh, Cynthia A. Cameron, José E. Abdenur et al. · Genetics in Medicine · 2011 · 349 citations · Full text

Metabolic Syndrome, Newborn Screening, Metabolic Disorder +10

Enhanced interpretation of newborn screening results without analyte cutoff values

Gregg Marquardt, Robert J. Currier, David McHugh et al. · Genetics in Medicine · 2012 · 123 citations · Full text

Early Diagnosis, Newborn Screening, Neonatology +8

Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis

Monique G. de Sain-van der Velden, George A. Kaysen, Hugh A. Barrett et al. · Kidney International · 1998 · 91 citations · Full text

Glomerulonephritis, Increased Synthesis, Urology +11

Evidence for increased synthesis of lipoprotein(a) in the nephrotic syndrome.

Monique G. de Sain-van der Velden, Dirk‐Jan Reijngoud, George A. Kaysen et al. · Journal of the American Society of Nephrology · 1998 · 83 citations · Full text

Hypertension, Renal Pathology, Hyperlipidemia +22

D‐serine in the developing human central nervous system

Sabine A. Fuchs, L. Dorland, Monique G. de Sain-van der Velden et al. · Annals of Neurology · 2006 · 54 citations